Dr. Sandip Vadariya

Employment

• Cohance Lifesciences limited Group Leader (Sr. Manager)-AR&D
  2015 - Present

Education

• The Charutar Vidya Mandal (CVM) University Doctor of Philosophy (PhD)
  2022 - 2025
• Bhavnagar University M.sc.
  2005 - 2007

Projects & Funding

Projects & funding information is unavailable.

Publications (7)

• Trace-Level Quantification and Identification of Mutagenic and Cohort-of-Concern N-nitroso-mirabegron Impurity (NDSRIs) using UFLC-ESI-MS/MS in Mirabegron
  Research Journal of Pharmacy and Technology 2026
  +Save
• Determination of Potential Genotoxic NDSRI (Nitrosamine Drug Substance Related Impurity) in Ticagrelor – Antiplatelet Medications: (Q) SAR Assessment, HPLC-ESI-MS/MS Method Development and Validation
  Journal of Carcinogenesis 2025
  +Save
• Development and Validation for the Quantification of Genotoxic Impurity in Mirabegron Drug Substance by LCMS
  Biomedical Chromatography 2025 DOI: 10.1002/bmc.70150
  +Save
• Development And Validation Of N-Nitroso Atomoxetine Impurity (Ndsri) Determination Method In Atomoxetine Hydrochloride With Uflc-Ms/Ms (Esi).
  South Eastern European Journal of Public Health 2025 DOI: 10.70135/seejph.vi.5447
  +Save
• Development and validation for the quantification of genotoxic impurities in Bempedoic acid drug by GC/MS
  Analytical Chemistry Letters 2025 DOI: 10.1080/22297928.2025.2458045
  +Save
• Development and Validation of Analytical Methods for the Quantification and Identification of N-Nitroso Trimetazidine, a Nitrosamine Impurity, in Drug Substance and Drug Product.
  2025 DOI: 10.22541/au.173924857.76644661/v1
  +Save
• Development and Validation of HPLC Method for the Quantification of Impending Genotoxic Impurities in Dapson Drug Substances
  Biotechnology Journal International 2024 DOI: 10.9734/bji/2024/v28i4724
  +Save